• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Bradley Prechtl Explains the Importance of Dispelling Patient Misconceptions of Clinical Trials

Video

I think there is a lot of confusion, especially in the patient community, about clinical research., explained Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network.

I think there is a lot of confusion, especially in the patient community, about clinical research, explained Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network.

Transcript

When offering clinical trials to patients, does this require dispelling misconceptions they might have about participating in a trial?

I think there is a lot of confusion, especially in the patient community, about clinical research. A lot of patients I think hear clinical research thinking they’re going to be some sort of guinea pig. They don’t know if it’s a real drug or a placebo or whatever the case may be. We’ve had so many patients that have been enrolled in clinical trials that were not progressing well with standard of care that they’ve had incredible outcomes. I think one of our goals is continuing to try and educate patients on what is clinical research and really dumbing it down because even people that are in healthcare, I think, often times have misconceptions about what clinical research really is.

Related Videos
Coral Omene, MD, PhD, sitting for a vieo interview
Dr Ola Landgren
David Awad, PharmD, BCOP
Gordon Crofoot, MD, PA
Jaime Almandoz, MD, MBA
Screenshot of Coral Omene, MD, PhD
Dr Brian Slomovitz
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy (AMCP)
ASCO 2025
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.